Dolutegravir 25 mg and 50 mg and Ropinirole Extended-Release Tablets
Determining the interaction of Dolutegravir 25 mg and 50 mg and Ropinirole Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Ropinirole Hydrochloride
- Dolutegravir 25 mg and 50 mg-Ropinirole Tablets
- Dolutegravir 25 mg and 50 mg-Ropivacaine
- Dolutegravir 25 mg and 50 mg-Ropivacaine Hydrochloride
- Dolutegravir 25 mg and 50 mg-Ropivacaine Injection
- Dolutegravir 25 mg and 50 mg-Rosac
- Ropinirole Extended-Release Tablets-Dolutegravir and lamivudine
- Ropinirole Extended-Release Tablets-Dolutegravir and rilpivirine
- Ropinirole Extended-Release Tablets-Dolutegravir Sodium
- Ropinirole Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Ropinirole Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Ropinirole Extended-Release Tablets-Dom-Etoposide